Literature DB >> 33233949

Using the concept of "deserved trust" to strengthen the value and integrity of biomedical research.

Mark Yarborough1.   

Abstract

It is commonplace for science leaders and others to claim that the future of biomedical research rests in large part upon the public's trust. If true, it behooves the biomedical research community to understand how it avoids taking chances with that trust. This commentary, which builds upon comments of noted trust scholar Russell Hardin about how best to enjoy trust, assumes that the key to being trusted is deserving to be trusted. Thus, it proposes using "deserved trust" to identify ways that the public's trust in biomedical research could be better supported. Employing deserved trust to support the public's trust leads us to consider what it is that the biomedical research community should be trusted to do, examine the evidence about the effectiveness of current safeguards meant to assure that those things routinely get done, and identify new ways to equip individual researchers, research teams, and research institutions to assure that the public's trust in their research is deserved rather than misplaced.

Entities:  

Keywords:  Public trust; research integrity; responsible conduct of research; translational research

Mesh:

Year:  2020        PMID: 33233949      PMCID: PMC8233402          DOI: 10.1080/08989621.2020.1855427

Source DB:  PubMed          Journal:  Account Res        ISSN: 0898-9621            Impact factor:   3.057


  52 in total

Review 1.  Increasing value and reducing waste in biomedical research: who's listening?

Authors:  David Moher; Paul Glasziou; Iain Chalmers; Mona Nasser; Patrick M M Bossuyt; Daniël A Korevaar; Ian D Graham; Philippe Ravaud; Isabelle Boutron
Journal:  Lancet       Date:  2015-09-27       Impact factor: 79.321

2.  The structure of clinical translation: efficiency, information, and ethics.

Authors:  Jonathan Kimmelman; Alex John London
Journal:  Hastings Cent Rep       Date:  2015-01-27       Impact factor: 2.683

3.  An "alarming" and "exceptionally high" rate of COVID-19 retractions?

Authors:  Alison Abritis; Adam Marcus; Ivan Oransky
Journal:  Account Res       Date:  2020-07-11       Impact factor: 2.622

4.  Publication bias in reports of animal stroke studies leads to major overstatement of efficacy.

Authors:  Emily S Sena; H Bart van der Worp; Philip M W Bath; David W Howells; Malcolm R Macleod
Journal:  PLoS Biol       Date:  2010-03-30       Impact factor: 8.029

5.  Look back in anger - what clinical studies tell us about preclinical work.

Authors:  Thomas Hartung
Journal:  ALTEX       Date:  2013       Impact factor: 6.043

Review 6.  Bringing rigour to translational medicine.

Authors:  David W Howells; Emily S Sena; Malcolm R Macleod
Journal:  Nat Rev Neurol       Date:  2013-11-19       Impact factor: 42.937

7.  Risk of Bias in Reports of In Vivo Research: A Focus for Improvement.

Authors:  Malcolm R Macleod; Aaron Lawson McLean; Aikaterini Kyriakopoulou; Stylianos Serghiou; Arno de Wilde; Nicki Sherratt; Theo Hirst; Rachel Hemblade; Zsanett Bahor; Cristina Nunes-Fonseca; Aparna Potluru; Andrew Thomson; Julija Baginskaite; Julija Baginskitae; Kieren Egan; Hanna Vesterinen; Gillian L Currie; Leonid Churilov; David W Howells; Emily S Sena
Journal:  PLoS Biol       Date:  2015-10-13       Impact factor: 8.029

8.  Distinguishing between exploratory and confirmatory preclinical research will improve translation.

Authors:  Jonathan Kimmelman; Jeffrey S Mogil; Ulrich Dirnagl
Journal:  PLoS Biol       Date:  2014-05-20       Impact factor: 8.029

9.  Rescuing Informed Consent: How the new "Key Information" and "Reasonable Person" Provisions in the Revised U.S. Common Rule open the door to long Overdue Informed Consent Disclosure Improvements and why we need to walk Through that door.

Authors:  Mark Yarborough
Journal:  Sci Eng Ethics       Date:  2019-12-23       Impact factor: 3.525

10.  Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource.

Authors:  Ben Goldacre; Nicholas J DeVito; Carl Heneghan; Francis Irving; Seb Bacon; Jessica Fleminger; Helen Curtis
Journal:  BMJ       Date:  2018-09-12
View more
  1 in total

1.  Research ethics and public trust in vaccines: the case of COVID-19 challenge trials.

Authors:  Nir Eyal
Journal:  J Med Ethics       Date:  2022-05-20       Impact factor: 5.926

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.